Things We Do for No Reason™: Routine use of triple anticoagulant therapy in patients with both nonvalvular atrial fibrillation and percutaneous coronary intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Things We Do for No Reason™: Routine use of triple anticoagulant therapy in patients with both nonvalvular atrial fibrillation and percutaneous coronary intervention

Published:2022-05-08 Issue:11 Volume:17 Page:917-920
ISSN:1553-5592
Container-title:Journal of Hospital Medicine
language:en
Short-container-title:Journal of Hospital Medicine

Author:

Garst Collins¹,Pitliya Anmol¹,Iannetti Michael¹^ORCID,Caccamo Marco²^ORCID

Affiliation:

1. Camden Clark Medical Center Parkersburg West Virginia USA

2. Department of Cardiology West Virginia University School of Medicine Morgantown West Virginia USA

Publisher

Wiley

Subject

Assessment and Diagnosis,Care Planning,Health Policy,Fundamentals and skills,General Medicine,Leadership and Management

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhm.12831

Reference15 articles.

1. Patients with atrial fibrillation and coronary artery disease – Double trouble

2. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society;January CT;J Am Coll Cardiol,2019

3. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome

4. Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention

5. Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP